Previous 10 | Next 10 |
Biotech Stocks: Global Revenues For Ophthalmology Market Projected To Reach $26 Billion By 2022 May 9, 2019 Palm Beach, FL –May 9, 2019 – As the baby boomer generation ages, there is an increased need… no… a demand by these aging patients to avert vision and...
May 7, 2019 Palm Beach, FL –May 7, 2019 – The patient demand for a better way to treat to glaucoma has been growing for years. Two recent reports from Transparency Market Research show that this growing worldwide consumer demand projects ever increasing revenues for both th...
In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, treatment with Lumega-Z was associated with significant improvement in Visual Field function among patients with severe glaucoma San Diego, CA, May 07, 2019 (GLOBE NEWSW...
Gainers: Aquantia (NYSE: AQ ) +36% . Sinclair Broadcast (NASDAQ: SBGI ) +28% . Athenex (NASDAQ: ATNX ) +25% . Bridgeline Digital (NASDAQ: BLIN ) +22% . Regulus Therapeutics (NASDAQ: RGLS ) +18% . Ovid Therapeutics (NASDAQ: OVID ) +17% . Daxor Corporation (NYSEMKT: DXR ) +17% ....
Guardion’s Lumega-Z product and MapcatSF device are key components of its two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment, a known risk factor for age-related macular degeneration San Diego, CA, May 01, 2019 (GLOBE NEWSWIRE) -- Guar...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc.’s (the “Company”) Scientific Advisory Board member, Dr. William Sponsel will be presenting an abstract at the Association for Research in Vision and Ophthalmology (“ARVO”) 2019 An...
JERSEY CITY, N.J. , April 11, 2019 /PRNewswire/ -- WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the closing of the initial public offering of 1,250,000 shares of common stock at a public offering price of $4.00 per share of G...
SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences Inc. (“Guardion”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing technologies supported by evidence...
News, Short Squeeze, Breakout and More Instantly...
Guardion Health Sciences Inc. Company Name:
GHSI Stock Symbol:
NASDAQ Market:
Guardion Health Sciences Inc. Website:
2024-07-21 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-11 20:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of co...